Abeona Therapeutics

ABEONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$324.233 M

$5.67 +1.80%

Close of 21 Sept 2026

Revenue

$5.82M

#3260 by revenue

Earnings

-$71.2M

Loss-making

Shares outstanding

57,184,017

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#230Perspective TherapeuticsCATX$339.0M
#231Emergent BioSolutionsEBS$335.8M
#232Abeona TherapeuticsABEO$324.2M
#233InflaRxIFRX$312.4M
#234Q32 BioQTTB$311.7M

What if Abeona Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$529,414.61

Per share 93,371× higher

Bitcoin $1.72T

$30,074.90

Per share 5,304× higher

Nvidia $5.48T

$95,828.49

Per share 16,901× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Abeona Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.